AI reads MRI scans to predict brain tumor type before surgery
NCT ID NCT07608003
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether an artificial intelligence (AI) model can accurately predict the molecular subtype of midline gliomas (a type of brain tumor) using MRI scans taken before surgery. Researchers will compare the AI's predictions with standard lab tests after surgery to see how well it works. The goal is to help doctors choose the best treatment plan without needing a biopsy first. The study will involve 500 patients across multiple hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA : OLIGODENDROGLIOMA OR ASTROCYTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410008, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain tumor drug vorasidenib tested in everyday practice
- PET-Guided surgery could extend life for aggressive brain cancer patients
- Brain tumor chemo delivered by pump shows promise in tiny safety trial
- New PET scan could slash radiation by 100x
- New hope for aggressive brain tumors: radioactive drug tested in small trial
- Smart MRI boosts brain cancer zapping therapy